IRIS
GEROLDI, DIEGO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.367
AS - Asia 2.329
EU - Europa 2.146
SA - Sud America 265
AF - Africa 88
Continente sconosciuto - Info sul continente non disponibili 25
OC - Oceania 6
Totale 8.226
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.301
CN - Cina 1.194
SG - Singapore 519
IE - Irlanda 463
UA - Ucraina 300
FI - Finlandia 272
DE - Germania 268
RU - Federazione Russa 227
BR - Brasile 210
HK - Hong Kong 198
VN - Vietnam 190
GB - Regno Unito 159
IT - Italia 125
FR - Francia 118
SE - Svezia 96
IN - India 62
ZA - Sudafrica 60
CA - Canada 36
JP - Giappone 27
BD - Bangladesh 26
BE - Belgio 26
PL - Polonia 25
IQ - Iraq 21
AR - Argentina 20
NL - Olanda 19
TR - Turchia 17
ES - Italia 16
MX - Messico 14
ID - Indonesia 11
SA - Arabia Saudita 10
UZ - Uzbekistan 10
MA - Marocco 9
CO - Colombia 8
EC - Ecuador 7
CZ - Repubblica Ceca 6
JO - Giordania 6
MY - Malesia 6
PK - Pakistan 6
AU - Australia 5
CL - Cile 5
CR - Costa Rica 5
PH - Filippine 5
VE - Venezuela 5
KE - Kenya 4
LT - Lituania 4
AT - Austria 3
IL - Israele 3
NP - Nepal 3
PE - Perù 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
BY - Bielorussia 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
LY - Libia 2
MU - Mauritius 2
NO - Norvegia 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
TN - Tunisia 2
UY - Uruguay 2
BB - Barbados 1
BS - Bahamas 1
BW - Botswana 1
CU - Cuba 1
GA - Gabon 1
HN - Honduras 1
HU - Ungheria 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
KR - Corea 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MK - Macedonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
ZM - Zambia 1
Totale 8.201
Salva come PNG Salva come JPEG
Città #
Dublin 463
Chandler 457
San Jose 403
Jacksonville 338
Singapore 287
Nanjing 272
Ashburn 249
Beijing 219
Hong Kong 192
Dallas 170
Boardman 125
Ann Arbor 116
Nanchang 104
Helsinki 97
Los Angeles 94
Council Bluffs 82
Munich 80
Princeton 80
Lawrence 73
Hebei 70
Shenyang 69
New York 68
Changsha 67
Medford 67
Lauterbourg 58
Hanoi 54
Ho Chi Minh City 54
Jiaxing 54
Johannesburg 52
Wilmington 50
Moscow 45
Tianjin 44
Hangzhou 42
Shanghai 37
Buffalo 35
Orem 29
Turku 29
Woodbridge 29
Milan 27
São Paulo 27
Brussels 26
Tokyo 24
Verona 23
Seattle 22
Norwalk 18
Warsaw 17
Brooklyn 16
Chennai 16
Santa Clara 16
London 13
Montreal 13
Piscataway 13
Redondo Beach 13
Des Moines 12
Manchester 12
Pavia 12
Toronto 12
Denver 11
Rio de Janeiro 11
Atlanta 10
Auburn Hills 10
Fairfield 10
Frankfurt am Main 10
Houston 10
Poplar 10
Da Nang 9
Haiphong 9
Mumbai 8
Tashkent 8
Amsterdam 7
Jinan 7
Washington 7
Zhengzhou 7
Baghdad 6
Istanbul 6
Jeddah 6
Ningbo 6
Stockholm 6
Taizhou 6
Berlin 5
Biên Hòa 5
Bắc Ninh 5
Campinas 5
Curitiba 5
Kunming 5
Mexico City 5
Naples 5
Tremestieri Etneo 5
Amman 4
Cape Town 4
Changchun 4
Chicago 4
Falkenstein 4
Hanover 4
Kuala Lumpur 4
Lanzhou 4
Medellín 4
Nairobi 4
Paris 4
Phoenix 4
Totale 5.459
Salva come PNG Salva come JPEG
Nome #
Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation. 167
Plasma eotaxin concentrations are associated with angiographic severity of coronary artery disease 158
Significato prognostico dei livelli plasmatici di osteopontina in pazienti con angina pectoris stabile 151
Approccio genetico-clinico alla cardiopatia ischemica: analisi di 14 casi familiari. 148
Absence of Kir6.1/KCNJ8 mutations in Italian patients with abnormal coronary vasomotion 146
Relationship between apolipoprotein(a) size polimorphism and coronary heart disease in overweight subjects 143
Decreased NT-3 plasma levels and platelet serotonin content in patients with hypochondriasis 142
Diabetes mellitus and silent myocardial ischemia in patients with coronary artery disease: comparison between patients with and without simptoms during provocative test. 141
La chemochina regolatoria eotaxina-3 quale nuovo fattore predittivo di outcome cardiovascolare in pazienti con angina pectoris stabile 140
Relationship between plasma levels of soluble receptor for advanced glycation end products (sRAGE) and coronary artery disease 140
374T/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis 139
RAGE : a central player in nondiabetic vascular disease 138
Raised plasma nerve growth factor levels associated with early-stage romantic love 138
Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men 137
Analisi mutazionale di Kir6.1/KCNJ8 in pazienti con angina vasospastica 136
A novel Val734Ile variant in the ABCC9 gene associated with myocardial infarction 134
Apo(a) isoforms: a genetic marker for progression of coronary atherosclerosis. 134
The apolipoprotein(a) component of lipoprotein(a) mediates binding to laminin:contribution to selective retention of lipoprotein(a) in atherosclerotic lesions. 133
The regulatory chemokine eotaxin-3 is a novel predictor of cardiovascular outcome in patients with coronary artery disease 132
Circulating levels of osteopontin predicts future cardiac events in patients with chronic stable angina 132
QT interval duration in apparently healthy men is associated with depression-related personality trait neuroticism 132
Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension 131
Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women 131
Forma solubile del recettore dei prodotti finali di glicazione avanzata (sRAGE) ed aterosclerosi coronarica 131
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary heart disease in patients with essential hypertension 130
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 130
Action of piracetam and clonidine on different mitochondrial populations from hippocampus 129
Association of lipoprotein(a) levels and apolipoprotein(a) phenotypes with coronary artery disease in Type 2 diabetic patients and in non-diabetic subjects 129
Association of plasma eotaxin levels with the presence and extent of angiographic coronary artery disease 125
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 125
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes 123
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 123
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: A 5 year follow-up study 121
High levels of soluble receptor for advanced glycation end products may be a marker of extreme longevity in humans 119
Cerebral ischemia and peripheral energy dysfunction in lymphocytes 118
Disfunzione erettile come predittore di eventi cardiovascolari maggiori in diabetici con coronaropatia silente angiograficamente documentata 115
Assessment of asymptomatic coronary artery disease in apparently uncomplicated type 2 diabetic patients: a role for lipoprotein(a) and apolipoprotein(a) polymorphism. 113
Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age. 111
Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk 109
Enzyme activities in perikaryal and synaptic mitochondrial fractions from rat hippocampus during development 108
Relationship between erectile dysfunction and silent myocardial ischemia in apparently uncomplicated type 2 diabetic patients 107
ATPases enzyme activities during ageing in different types of somatic and synaptic plasma membranes from rat frontal cerebral cortex 107
Apolipoprotein(a) phenotypes and their predictive value for coronary heart disease: identification of an operative cut-off of apolipoprotein(a) polymorphism. 106
High Lp(a) levels and atherogenic isoforms in patients with acute coronary sindrome 105
Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease 105
Apolipoprotein(a) phenotypes are reliable biomarkers for familial aggregation of coronary heart disease 104
Circulating levels of soluble receptor for advanced glycation end products in neurodegenerative and vascular dementia 100
Silent myocardial ischemia in diabetic and nondiabetic patients with coronary artery disease. 100
Prognostic significance of plasma osteopontin levels in patients with chronic stable angina 100
Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus 99
Genetic loading on human loving styles 99
Functional proteomics of energy-linked enzymes in lymphocytes after stroke. 97
The -374T/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease. 96
Matrix metalloproteinase 2 may be a marker of microangiopathy compared to metalloproteinase 9 in children and adolescents with type 1 diabetes mellitus: a 5-year follow-up study 94
Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target 93
Matrix metalloproteinase 2 and 9 evaluation in patients with or without diabetes during acute coronary syndrome and after the acute event 93
Restenosis after intracoronary stent placement: can apolipoprotein(a) polymorphism play a role? 91
Increased Plasma Aldosterone Concentrations in Patients with Clinical Depression 90
Fenotipi di apolipoproteina(a) come indicatori di suscettibilità genetica per rischio cardiovascolare in medicina del lavoro 88
The apolipoprotein(a) size polymorphism is assocated with Alzheimer's disease and vascular dementia 85
Factors involved in drug interference on enzyme activities of three mitochondrial populations from rat hippocampus 84
Erectile dysfunction and angiographic extent of coronary artery disease in type II diabetic patients 79
Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes 78
Peripheral energy dysfunction in cerebral ischemia: focus on lymphocytes. 77
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 77
Relationship between platelet serotonin content and rejections of unfair offers in the ultimatum game. 76
Prevalenza di elevati livelli di Lp(a) e di isoforme aterogene in un gruppo di pazienti del Nord Italia con sindrome coronarica acuta 76
Energy metabolism of mitochondria after ischemia and recovery times during aging and peripheral energy dysfunction in stroke patients: focus on lymphocytes 76
Valutazione delle metalloproteasi 2 e 9 in pazienti con o senza diabete durante sindrome coronarica acuta e dopo evento acuto 74
Relationship between apolipoprotein(a) size polymorphism and coronary heart disease in overweight subjects 73
Energy metabolism of lymphocytes from acute stroke patients 73
Lymphocytes bioenergetics after stroke: a functional proteomic study 73
Mitochondrial Energy Metabolism of Brain and Lymphocytes after Ischemia and Recovery during Aging 69
Totale 8.226
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.198
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022319 0 3 9 8 2 5 8 20 16 19 49 180
2022/20231.338 139 107 17 98 149 124 0 78 556 17 34 19
2023/2024424 77 85 11 26 34 95 4 37 3 13 19 20
2024/20251.128 18 82 50 32 34 38 44 80 290 33 149 278
2025/20262.653 219 140 258 304 325 143 635 111 199 165 109 45
2026/2027134 39 95 0 0 0 0 0 0 0 0 0 0
Totale 8.226